Tel :
+33(0)5 55 05 69 83
Courriel :
secretariat.cic@chu-limoges.fr
Adresse
2 Av. Martin Luther King, Limoges

PUBLICATIONS

2025 - 2024 - 2023 - 2022

Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study (EXPECT-2).

Doua J, Rodríguez-Baño J, Froget R, Puranam P, Go O, Geurtsen J, van Rooij S, Vilken T, Minoru I, Yasumori I, Spiessens B, Tacconelli E, Biehl LM, Thaden JT, Sarnecki M, Goossens H, Poolman J, Bonten M, Ekkelenkamp M; COMBACTE-NET Consortium/EXPECT Study Group.

Infection. Jun 2024 ; doi:10.1007/s15010-023-02163-z
Effect of mesenchymal stem cells on the host response in severe community-acquired pneumonia (SEPCELL Study)

Reijnders TDY, Laterre PF, François B, Sánchez García M, van Engelen TSR, Sie D, Scicluna BP, Ostanin DV, Galinsky KJ, Butler JM, Lombardo E, van der Poll T; SEPCELL study group.

Thorax. Oct 2024 ; doi: 10.1136/thorax-2024-222026
Influence of Socioeconomic Deprivation on Surgical Outcomes for Patients With Sigmoid Diverticulitis in France: A Multicenter Retrospective Study.

Alves A, Sabbagh C, Ouaissi M, Zerbib P, Bridoux V, Manceau G, Panis Y, Buscail E, Venara A, Khaoudy I, Gaillard M, Viennet M, Thobie A, Menahem B, Eveno C, Bonnel C, Mabrut JY, Badic B, Godet C, Eid Y, Duchalais E, Lakkis Z, Cotte E, Laforest A, Defourneaux V, Maggiori L, Rebibo L, Christou N, Talal A, Mege D, Bonnamy C, Germain A, Mauvais F, Tresallet C, Roudie J, Laurent A, Trilling B, Bertrand M, Massalou D, Romain B, Tranchart H, Pellegrin A, Beyer-Berjot L, Dejardin O; French Surgical Association.

(Remerciements: P Engel, M Mathonnet)

Annals of Surgery. Nov 2024 ; doi: 10.1097/SLA.0000000000006497.
SEPSIGN: early identification of sepsis signs in emergency department.

Lafon T, Cazalis MA, Hart KW, Hennessy C, Tazarourte K, Self WH, Akhavan AR, Laribi S, Viglino D, Douplat M, Ginde AA, Tolou S, Mahler SA, Le Borgne P, Claessens YE, Yordanov Y, Le Bastard Q, Pancher A, Ducharme J, Lindsell CJ, Shapiro NI.

Internal and Emergency Medicine. Oct 2024 ; doi: 10.1007/s11739-024-03802-5.
A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer (TROPIC Study).

Zhang K, Stricker P, Löhr M, Stehling M, Suberville M, Cussenot O, Lunelli L, Ng CF, Teoh J, Laguna P, de la Rosette J.

Prostate Cancer and Prostatic Diseases. Sept 2024 ;